Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PX-866 and Cetuximab in Advanced CRC and SCCHN
NCT01252628Phase 2Completed
- Sponsor
- Cascadian Therapeutics
- Start
- Dec 2010
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sonolisib in colorectal carcinoma (CRC), squamous cell carcinoma of the head and neck (HNSCC), sponsored by Cascadian Therapeutics. Started Dec 2010; status: completed.
02
Drugs
sonolisib
03
Conditions
colorectal carcinoma (CRC)squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01252628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01252628.